NCT03368937View on ClinicalTrials.gov

A Pilot Test of t:Slim X2 With Control-IQ Technology

NACompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

December 8, 2017

Primary Completion Date

December 11, 2017

Study Completion Date

December 11, 2017

Conditions
Type1 Diabetes Mellitus
Interventions
DEVICE

Tandem t:slim X2 with Control-IQ Technology

Subjects will wear the Tandem t:slim X2 with Control-IQ Technology during a 36-48 hour hotel admission.

Trial Locations (1)

22903

University of Virginia Center for Diabetes Technology, Charlottesville

All Listed Sponsors
collaborator

Tandem Diabetes Care, Inc.

INDUSTRY

collaborator

DexCom, Inc.

INDUSTRY

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Virginia

OTHER

NCT03368937 - A Pilot Test of t:Slim X2 With Control-IQ Technology | Biotech Hunter | Biotech Hunter